Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise Obrecht-Sturm

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancers|June 19, 2024
Radiotherapy for Recurrent Medulloblastoma in Children and Adolescents: Survival after Re-Irradiation and First-Time IrradiationJonas E Adolph, Gudrun Fleischhack, Sebastian Tschirner, et al.
Neuro-Oncology|June 5, 2024
Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trialMartin Mynarek, Anne Rossius, Anika Guiard, et al.
Neuro-Oncology|August 22, 2024
Distinct relapse pattern across molecular ependymoma typesDenise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.
Neuro-Oncology|September 30, 2025
Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registriesKatja von Hoff, Denise Obrecht-Sturm, David R Ghasemi, et al.
Pediatric Blood & Cancer|March 17, 2026
The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and SwitzerlandStefan Rutkowski, Michael C Frühwald, Gudrun Fleischhack, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancers|June 19, 2024
Radiotherapy for Recurrent Medulloblastoma in Children and Adolescents: Survival after Re-Irradiation and First-Time IrradiationJonas E Adolph, Gudrun Fleischhack, Sebastian Tschirner, et al.
Neuro-Oncology|June 5, 2024
Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trialMartin Mynarek, Anne Rossius, Anika Guiard, et al.
Neuro-Oncology|August 22, 2024
Distinct relapse pattern across molecular ependymoma typesDenise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.
Neuro-Oncology|September 30, 2025
Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registriesKatja von Hoff, Denise Obrecht-Sturm, David R Ghasemi, et al.
Pediatric Blood & Cancer|March 17, 2026
The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and SwitzerlandStefan Rutkowski, Michael C Frühwald, Gudrun Fleischhack, et al.
Pageof 2